United Kingdom · Question · Written question
UIN 346
Cystic Fibrosis: Drugs
Original
Introduced
7 November 2023
Last action
9 November 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
9 November 2023
Summary
To ask the Secretary of State for Health and Social Care, whether it is his Department's policy that people with cystic fibrosis will have access to (a) Orkambi, (b) Symkevi and (c) Kaftrio through the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 November 2023
Written question
To ask the Secretary of State for Health and Social Care, whether it is his Department's policy that people with cystic fibrosis will have access to (a) Orkambi, (b) Symkevi and (c) Kaftrio through the NHS.
Source: Commons
9 November 2023
Answer
Orkambi, Symkevi and Kaftrio are currently available as treatment options for eligible National Health Service patients with cystic fibrosis, under the terms of a commercial agreement reached between NHS England and the manufacturer. This agreement has en...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-07/346
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1667958
- uk · wq-1667958 · source updated 9 November 2023